Search Login Register
montelukast
(Singulair)
Summary
Description:
a leukotriene D4 receptor antagonist; sodium salt is the active compound; structure in first source
Also Known As:
Singulair; Cahill May Roberts brand of montelukast sodium; MK 0476; MK-0476; Merck Frosst brand of montelukast sodium Show All >>
Networked: 1091
relevant articles (269 outcomes,
362 trials/studies)
for this Drug
Key Diseases for which montelukast is
Relevant
-
Asthma (Bronchial Asthma)
:
158 outcomes 221 studies in 644 results
-
Rhinitis
:
28 outcomes 29 studies in 119 results
-
Inflammation
:
15 outcomes 34 studies in 106 results
-
Seasonal Allergic Rhinitis (Hay Fever)
:
15 outcomes 11 studies in 43 results
-
Urticaria (Hives)
:
8 outcomes 11 studies in 28 results
Show All >>
Drugs Related to montelukast
-
fluticasone (Cutivate)
-
Leukotriene Receptors (Leukotriene Receptor)
-
salmeterol (Serevent)
-
Adrenal Cortex Hormones (Corticosteroids)
-
Budesonide (Pulmicort)
-
Loratadine (Alavert)
-
leukotriene D4 receptor (cysteinyl leukotriene receptor)
-
Aspirin (Acetylsalicylic Acid)
-
Leukotriene Antagonists (Leukotriene Receptor Antagonists)
-
desloratadine (Aerius)
Show All >>
Therapies Related to montelukast
-
Aftercare (After-Treatment)
-
Nebulizers and Vaporizers (Inhaler)
-
Immunotherapy
-
Respiratory Therapy (Therapy, Respiratory)
-
Prostheses and Implants (Prosthesis)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.